Association between Genotype and the HBsAg Levels at HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir or Peginterferon Alfa-2a

被引：0
|
作者：
Peng, Cheng-Yuan [1 ]
Lai, Hsueh-Chou [1 ]
Su, Wen-Pang [1 ]
Lin, Chia-Hsin [1 ]
Chuang, Po-Heng [1 ]
Chen, Sheng-Hung [1 ]
机构：
[1] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1911
引用
收藏
页码：1121A / 1121A
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Peng, C. -Y.
    Lai, H. -C.
    Su, W. -P.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S430 - S430
  • [2] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [3] ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
    Lau, G. K. K.
    Marcellin, P.
    Brunetto, M.
    Piratvisuth, T.
    Kapprell, H. -P
    Messinger, D.
    Popescu, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S333 - S333
  • [4] COMPARISON OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B WITH MILDLY ELEVATED ALANINE AMINOTRANSFERASE LEVELS
    Chen, X. -F.
    Chen, X. -P.
    Huang, J.
    Chen, W. -L.
    Chen, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S328 - S329
  • [5] Efficacy and safety of peginterferon alfa-2a in Chinese patients with HBeAg-positive chronic hepatitis B
    Xu, D. -Z.
    Xie, Y.
    Wei, L.
    Chen, X. Y.
    Wan, M. -B.
    Wang, Y. -M.
    Wang, L.
    Wei, J.
    Gan, J. -H.
    Tian, D. -Y.
    Zhang, S. -L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S266
  • [6] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [7] COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
    Sheng, F.
    VALUE IN HEALTH, 2009, 12 (07) : A428 - A429
  • [8] New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a induces HBeAg seroconversion/HBsAg clearance in patients with HBeAg-positive chronic hepatitis B
    Ning, Qin
    Han, Meifang
    Sun, Yongtao
    Jiang, Jia-ji
    Tan, Deming
    Hou, Jinlin
    Tang, Hong
    Sheng, Jifang
    Zhao, Mianzhi
    HEPATOLOGY, 2012, 56 : 300A - 301A
  • [9] A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B
    Chan, H. L. Y.
    Messinger, D.
    Papatheodoridis, G. V.
    Cornberg, M.
    Xie, Q.
    Piratvisuth, T.
    Ren, H.
    Kennedy, P. T.
    Thompson, A.
    Caputo, A.
    Bakalos, G.
    Pavlovic, V.
    Lampertico, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (05) : 547 - 555
  • [10] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
12345